Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) had its target price trimmed by Piper Sandler from $5.00 to $3.00 in a research note published on Monday morning, The Fly reports. Other analysts also recently issued research reports about the stock. StockNews.com initiated coverage on shares of Amneal Pharmaceuticals in a report on Friday, March 17th. They […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating)’s stock price gapped up prior to trading on Monday following a better than expected earnings announcement. The stock had previously closed at $1.92, but opened at $2.00. Amneal Pharmaceuticals shares last traded at $1.94, with a volume of 81,318 shares changing hands. The company reported $0.10 earnings per […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) shares rose 5.6% during mid-day trading on Wednesday . The company traded as high as $1.81 and last traded at $1.81. Approximately 477,721 shares changed hands during trading, a decline of 54% from the average daily volume of 1,032,505 shares. The stock had previously closed at $1.71. Wall […]
Shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) have earned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective […]